Meet us @

MEDICAL FAIR THAILAND

BANGKOK, THAILAND
11-13 September 2019
BOOTH P12

MEDICA

DUSSELDORF, GERMANY
18-21 November 2019
BOOTH 15B16

TEXERE BIOTECH

THE BEST Human TISSUES, FOR ALL.

The world’s first fully robotic line offering revolutionary improvements in the processing of human tissue.

Healthcare around the world is facing growing challenges: aging population, increasing burden of diseases, but also waste of resources and in particular precious human tissue. Global healthcare spending is expected to continue growing. The current technologies are struggling to deliver high-quality and affordable products that returns people to fuller and more productive lives. Our robotized advanced machining process recycles human tissue from donor and make them the source of the best allograft quality at the most affordable cost for repairing, replacing, restoring and regenerating tissue for receiving patient.

The best technology for producing bone allograft​

TEXERE Biotech is bringing innovative technology solution for the optimal processing of human tissue, in particular for the production of bone allograft.

OUR VISION

Our vision is to use advanced automation and robotized technologies to contribute to solve healthcare challenges: providing a better access, improve outcomes and lower overall costs of patient care to restore health and extend life for patient around the world.

OUR MISSION

Our mission is to build forefront robotization processing lines to drive progress and innovation for better recycling of human tissue with proven clinical and economic value.

OUR PROPOSAL

Our automation process recycles human tissue from donor and make them the source of the best allograft quality at the most affordable cost for repairing, replacing, restoring and regenerating tissue for receiving patient.

Serving bone banks

PRODUCING BONE ALLOGRAFT

Donated femoral heads collected by the bone banks are sent to our plant for transformation into freeze-dried bone allograft (FDBA) blocks.

SAFETY & RELIABILITY

Bone tissue is processed by our unique robotized advanced machining BONEFIDE® process. Each femoral head is treated individually, hence eliminating all risks of cross-contamination.

COMPLETE TRACEABILITY

Our BONEFIDE® process has been developed according to GMP guidelines and does provide full traceability for each produced bone allograft block.

technology provider

GLOBAL TURNKEY SOLUTION

Our automated robotized and compact processing line is available as a plug-in/ready-to-start turnkey solution for export. The line is build in maritime containers and fully qualified prior to shipment.

TECHNOLOGY TRANSFER

We do provide with each processing line the complete technology transfer and training of your personnel, so that you can start your production without any delay.

LICENSING AGREEMENT

Our technology is continuously being improved and throughout our licensing agreement, that is included within each turnkey project, you have the best guarantee to stay up to date with the most advanced tissue processing technology.

BONEFIDE®

Respecting bone tissue

BONEFIDE® is an advanced machining, fully automated and robotized process, to treat human tissues in view to guarantee:

  1. the integrity of the ultrastructure and the biological properties of bone
  2.  the safety by individual processing eliminating all risks of cross-contamination
  3. the best cost/effectiveness ratio for tissue banks

Our team

WHO we are

TEXERE Biotech, a Belgium based company incorporated in 2016, has been co-founded by three partners. 

These partners have joined their various medical, industrial and robotics expertise with the vision to use advanced automated technologies (known as “smart factory-industry 4.0”) to contribute to solve today’s and future healthcare challenges by:

  • providing a better access,
  • improve outcomes,
  • and lowering overall costs

of patient care to restore health and extend life for people around the world.

0
# Total hips arthroplasty in Europe each year
0
# Bone allografts used in Europe each year

Latest news